Samchundang Pharm Co Ltd 000250
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- KRW 111,000.00
- Day Range
- KRW 105,500.00–116,800.00
- 52-Week Range
- —–—
- Bid/Ask
- KRW 112,700.00 / KRW 112,800.00
- Market Cap
- KRW 2.56 Tril
- Volume/Avg
- 1.3 Mil / 1.3 Mil
Key Statistics
- Price/Earnings (Normalized)
- 1,091.88
- Price/Sales
- 13.26
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Samchundang Pharm Co Ltd is engaged in manufacturing, distributing, importing, and exporting pharmaceuticals in South Korea. The company offers ophthalmology, cardiovascular, endocrinology, antibacterial, anti-fungal, antiviral, respiratory, anti-inflammatory, antihistamine, and musculoskeletal products, as well as gastro intestines and vitamins.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 402
- Website
- http://www.scd.co.kr
Comparables
Valuation
|
Metric
|
000250
|
140410
|
016580
|
|---|---|---|---|
Price/Earnings (Normalized) | 1,091.88 | — | 7.39 |
Price/Book Value | 11.52 | 23.43 | 0.61 |
Price/Sales | 13.26 | 41.69 | 0.95 |
Price/Cash Flow | 112.57 | — | 5.64 |
Price/Earnings
000250
140410
016580
Financial Strength
|
Metric
|
000250
|
140410
|
016580
|
|---|---|---|---|
Quick Ratio | — | 1.98 | 3.93 |
Current Ratio | 2.69 | 2.34 | 5.30 |
Interest Coverage | −1.85 | −34.58 | 1,345.19 |
Quick Ratio
000250
140410
016580
Profitability
|
Metric
|
000250
|
140410
|
016580
|
|---|---|---|---|
Return on Assets (Normalized) | 2.87% | −17.65% | 7.92% |
Return on Equity (Normalized) | 5.77% | −33.91% | 8.87% |
Return on Invested Capital (Normalized) | 3.21% | −28.13% | 7.89% |
Return on Assets
000250
140410
016580
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Klqwrbgp | Wxjgl | $79.4 Bil | |
MKKGY
| Merck KGaA ADR | Mdxftpvcjn | Jrnrpf | $79.0 Bil | |
HLN
| Haleon PLC ADR | Zblxkkhlx | Mfdx | $38.5 Bil | |
VTRS
| Viatris Inc | Zgybjktf | Zsxcz | $13.1 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Whggvrfkx | Nvfct | $11.7 Bil | |
CTLT
| Catalent Inc | Bmfrbpqbm | Vdrzcbb | $10.0 Bil | |
CURLF
| Curaleaf Holdings Inc | Trbjmzfz | Qtxhp | $4.2 Bil | |
PRGO
| Perrigo Co PLC | Ckxfvzty | Dhjw | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Mdmsrjtb | Ztpjgz | $3.2 Bil | |
GTBIF
| Green Thumb Industries Inc | Zsbvsqxz | Bcc | $3.1 Bil |